TabletsMRP Under Process
Official PMBI MRP is being updated for catalog code 2146.
Locate Jan Aushadhi KendraClinical Overview
Combikit of Eplerenone Tablets 25mg + Torsemide Tablets 10mg is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with a full glass of water at scheduled times as prescribed. Maintain regular blood pressure and cardiac monitoring; do not discontinue abruptly.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Dizziness, headache, mild fatigue, gastrointestinal distress, postural hypotension. Rare/Severe: Severe hypotension, electrolyte imbalances, heart block, and hypersensitivity reactions.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Prescription cardiovascular medication. Do not discontinue without medical consultation, as abrupt cessation may cause rebound hypertension or cardiac events. Regularly monitor blood pressure and organ function.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified cardiologist/pharmacist before initiating, altering, or substituting any cardiovascular medication.
Torsemide Tablets 20 mg
Torsemide Tablets 20 mg is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Eplerenone Tablets 25 mg
Eplerenone Tablets 25 mg is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Torsemide 10mg + Spironolactone 50mg Tablets
Spironolactone is a synthetic steroid competitive mineralocorticoid receptor (aldosterone) antagonist and potassium-sparing diuretic on the WHO Model List of Essential Medicines. It blocks aldosterone binding in the late distal renal tubules and cortical collecting ducts, increasing sodium and water excretion while conserving potassium and hydrogen ions. In heart failure, it blocks aldosterone-mediated myocardial fibrosis and endothelial dysfunction. Indicated for heart failure with reduced ejection fraction (NYHA class II-IV), primary hyperaldosteronism, cirrhosis with ascites, resistant hypertension, and nephrotic edema.
Torsemide Tablets 40mg
Torsemide / Torasemide Tablets (5mg, 40mg) is a long-acting pyridine-sulfonylurea loop diuretic on the WHO Model List framework. It inhibits the Na+/K+/2Cl- carrier system in the thick ascending limb of Henle's loop, blocking active sodium and chloride reabsorption. It features high oral bioavailability (~80%), consistent absorption regardless of intestinal mucosal edema, and an extended duration of action (~12 hours) with anti-aldosteronergic properties that cause less potassium wasting than furosemide. Indicated for treatment of edema associated with congestive heart failure, chronic kidney disease (CKD), nephrotic syndrome, hepatic cirrhosis, and management of hypertension.